# Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention

> **NCT01487577** · PHASE2 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 19 (actual)

## Conditions studied

- Allogeneic Blood and Marrow Transplantation (BMT)
- Graft Versus Host Disease

## Interventions

- **DRUG:** Mycophenolate mofetil

## Key facts

- **NCT ID:** NCT01487577
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2014-12
- **Final completion:** 2016-01
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2016-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01487577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01487577, "Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01487577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*